Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Oligometastatic Prostate Cancer: Results of a Dutch Multidisciplinary Consensus Meeting.
Eur Urol Oncol. 2020 Apr;3(2):231-238. doi: 10.1016/j.euo.2019.07.010. Epub 2019 Aug 8.
Eur Urol Oncol. 2020.
PMID: 31401014
Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer.
Leyten GH, Hessels D, Jannink SA, Smit FP, de Jong H, Cornel EB, de Reijke TM, Vergunst H, Kil P, Knipscheer BC, van Oort IM, Mulders PF, Hulsbergen-van de Kaa CA, Schalken JA.
Leyten GH, et al.
Eur Urol. 2014 Mar;65(3):534-42. doi: 10.1016/j.eururo.2012.11.014. Epub 2012 Nov 15.
Eur Urol. 2014.
PMID: 23201468
Item in Clipboard
Prostate cancer biomarker profiles in urinary sediments and exosomes.
Dijkstra S, Birker IL, Smit FP, Leyten GH, de Reijke TM, van Oort IM, Mulders PF, Jannink SA, Schalken JA.
Dijkstra S, et al. Among authors: leyten gh.
J Urol. 2014 Apr;191(4):1132-8. doi: 10.1016/j.juro.2013.11.001. Epub 2013 Nov 7.
J Urol. 2014.
PMID: 24211598
Item in Clipboard
Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score.
Van Neste L, Hendriks RJ, Dijkstra S, Trooskens G, Cornel EB, Jannink SA, de Jong H, Hessels D, Smit FP, Melchers WJ, Leyten GH, de Reijke TM, Vergunst H, Kil P, Knipscheer BC, Hulsbergen-van de Kaa CA, Mulders PF, van Oort IM, Van Criekinge W, Schalken JA.
Van Neste L, et al. Among authors: leyten gh.
Eur Urol. 2016 Nov;70(5):740-748. doi: 10.1016/j.eururo.2016.04.012. Epub 2016 Apr 20.
Eur Urol. 2016.
PMID: 27108162
Item in Clipboard
KLK3, PCA3, and TMPRSS2-ERG expression in the peripheral blood mononuclear cell fraction from castration-resistant prostate cancer patients and response to docetaxel treatment.
Dijkstra S, Leyten GH, Jannink SA, de Jong H, Mulders PF, van Oort IM, Schalken JA.
Dijkstra S, et al. Among authors: leyten gh.
Prostate. 2014 Sep;74(12):1222-30. doi: 10.1002/pros.22839. Epub 2014 Jul 7.
Prostate. 2014.
PMID: 25043536
Item in Clipboard
Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer.
Leyten GH, Hessels D, Smit FP, Jannink SA, de Jong H, Melchers WJ, Cornel EB, de Reijke TM, Vergunst H, Kil P, Knipscheer BC, Hulsbergen-van de Kaa CA, Mulders PF, van Oort IM, Schalken JA.
Leyten GH, et al.
Clin Cancer Res. 2015 Jul 1;21(13):3061-70. doi: 10.1158/1078-0432.CCR-14-3334. Epub 2015 Mar 18.
Clin Cancer Res. 2015.
PMID: 25788493
Item in Clipboard
Value of PCA3 to predict biopsy outcome and its potential role in selecting patients for multiparametric MRI.
Leyten GH, Wierenga EA, Sedelaar JP, van Oort IM, Futterer JJ, Barentsz JO, Schalken JA, Mulders PF.
Leyten GH, et al.
Int J Mol Sci. 2013 May 28;14(6):11347-55. doi: 10.3390/ijms140611347.
Int J Mol Sci. 2013.
PMID: 23759986
Free PMC article.
Item in Clipboard
Personalized management in low-risk prostate cancer: the role of biomarkers.
Dijkstra S, Hamid AR, Leyten GH, Schalken JA.
Dijkstra S, et al. Among authors: leyten gh.
Prostate Cancer. 2012;2012:327104. doi: 10.1155/2012/327104. Epub 2012 Dec 13.
Prostate Cancer. 2012.
PMID: 23304520
Free PMC article.
Item in Clipboard
Cite
Cite